(Q51564258)

7 April 2018

title

HDL-cholesterol reductions associated with adult growth hormone replacement. (English)

1 reference

7 April 2018

author name string

Leese GP

1

1 reference

7 April 2018

Wallymahmed M

2

1 reference

7 April 2018

VanHeyningen C

3

1 reference

7 April 2018

Tames F

4

1 reference

7 April 2018

Wieringa G

5

1 reference

7 April 2018

MacFarlane IA

6

1 reference

7 April 2018

publication date

1 November 1998

1 reference

7 April 2018

published in

Clinical Endocrinology

1 reference

7 April 2018

volume

49

1 reference

7 April 2018

issue

5

1 reference

7 April 2018

page(s)

673-677

1 reference

7 April 2018

The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Evidence for the role of the secretory pattern of growth hormone in the regulation of serum concentrations of cholesterol and apolipoprotein E in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Growth hormone regulation of serum lipoproteins in the rat: different growth hormone regulatory principles for apolipoprotein (apo) B and the sexually dimorphic apo E concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Influence of fitness status on very-low-density lipoprotein subfractions and lipoprotein(a) in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00597.X

10.1046/J.1365-2265.1998.00597.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018